Improved design and intranasal delivery of an M2e-based human influenza A vaccine
- 1 November 2006
- Vol. 24 (44-46) , 6597-6601
- https://doi.org/10.1016/j.vaccine.2006.05.082
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- The universal influenza vaccine M2e-HBc administered intranasally in combination with the adjuvant CTA1-DD provides complete protectionVaccine, 2006
- Large-scale sequencing of human influenza reveals the dynamic nature of viral genome evolutionNature, 2005
- Influenza vaccination coverage rates in five European countries—a population-based cross-sectional analysis of two consecutive influenza seasonsVaccine, 2005
- High epitope density in a single recombinant protein molecule of the extracellular domain of influenza A virus M2 protein significantly enhances protective immunityVaccine, 2004
- Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeysVaccine, 2004
- Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2Vaccine, 2003
- InfluenzaThe Lancet, 1999
- Human influenza virus A/HongKong/156/97 (H5N1) infectionVaccine, 1998
- Antibody response to the M2 protein of influenza A virus expressed in insect cellsJournal of General Virology, 1993
- Synthesis of hepatitis B virus e antigen in E. coliVirus Research, 1989